Probiotic OEM Cost Breakdown: What Drives Stick Pack Price
Two quotes for the same fill weight can differ by a third; here is where that difference actually lives, module by module.

A per-stick price is not a price for a stick. It is the sum of five cost modules, and two suppliers quoting the same gram weight against the same CFU claim can land 30 to 50 percent apart without either of them being dishonest. For buyers and formulators the gap matters because the number that ends up in the purchase order decides whether the label claim still holds at the end of shelf life. The practical response at RFQ stage is to stop comparing single unit prices and start comparing itemized quotes, so the difference can be attributed to a specific module instead of averaged into one number that hides everything.
The five modules are probiotic powder, excipients and flavor system, packaging material, processing fee, and testing plus compliance documentation. Powder is normally priced by potency delivered rather than by weight, which is why two quotes for the same milligram fill can carry very different powder costs. Excipients and flavor are priced by formula percentage and by whether the flavor system is a stock item or a custom blend. Packaging is priced by film structure, print method and order quantity. Processing is priced by fill weight, line speed and changeover count. Testing and documentation are priced per batch and per test panel. Each module has its own leverage, and each responds differently to volume.
The module most often underestimated is the stick film. A barrier laminate for a powder stick is a multi-layer structure with a sealing layer, and the price per kilogram depends on which barrier layers are specified and how many colors are printed. Cylinder or plate engraving for artwork is a one-time charge that has to be amortized over the order, and film suppliers set their own minimum order quantity per SKU, which is frequently higher than the filling minimum. Film also carries a real loss rate: run-up and registration trim at start, sealing trials, and the leftover partial roll at the end of a run. Those kilograms are paid for but never shipped.
Small orders are expensive for a structural reason rather than a commercial one. Line clearance, first-article confirmation, retention samples, batch documentation and quality release are fixed costs per run. Spreading them over a few thousand sticks rather than a few hundred thousand is what makes the left side of the price curve steep. It is also why a second quote at triple the volume often drops disproportionately, and why a buyer should model the annual requirement before negotiating a single batch.
Powder is the dominant variable. Strain-level pricing differs widely, driven by how demanding the organism is to cultivate, how it behaves through processing and storage, and how much documented work exists behind it. Blending several strains does not simply average their prices: it adds formulation time, raises the analytical burden because each strain may need its own enumeration or identification approach, and increases the number of release tests per batch. That is the real trade-off behind a multi-strain story on the front of the pack. Fewer, better-supported strains usually cost less to guarantee than a long list that is hard to verify.
The distinction that decides powder cost is labeled CFU against input CFU. The label promises a count at the end of shelf life; the fill has to start above that number to survive processing losses, sealing heat, moisture ingress and the decay that continues in storage. The gap between fill potency and end-of-shelf-life potency is the overage, and every point of overage is powder that is paid for and consumed without appearing on the label. Overages should come from stability data on the actual matrix and package, not from habit. A supplier who quotes without asking about your target shelf life, storage conditions and film structure is quoting a number that has not been designed.
There are legitimate ways to reduce the powder line. Inactivated organisms and postbiotic preparations avoid the viability requirement altogether, which removes the overage logic and can simplify testing, but they support a different claim set and a different consumer story, so the saving is only real if the positioning allows it. Encapsulation and protective coating run the other direction: they add cost per kilogram, yet they can lower the overage needed and widen the range of film structures and distribution conditions the product tolerates. Whether that pays depends on whether viability through a harsh matrix is part of the promise.
Order structure then reshapes everything above. Minimum order quantities come in pairs, one for finished goods and one for film, and the binding constraint is usually the film. Tiered pricing exists because each tier spreads fixed cost over more units, so a twelve-month framework volume with scheduled releases generally buys a better unit price than the same total split into ad hoc lots, without the inventory risk of one large delivery. Changeover and cleaning between SKUs cost money and time, and allergen plus strain cross-contamination controls restrict which products can follow each other on a line. In peak season, expedite fees reflect overtime, line priority and higher scrap rather than arbitrariness.
A quote that cannot be broken into modules is a quote that cannot be audited, and a unit price you cannot audit is a risk transfer, not a discount.
With an itemized quote in hand, negotiation becomes a matter of sorting rather than haggling. Pack size, film specification within claim-safe limits, batch structure, release schedule, payment terms and delivery windows are all movable. Fill potency, the data behind the overage, the test panel, retention samples and the stability protocol are not, because cutting them moves risk onto the brand and onto the consumer. Ask for third-party viability testing and a stability protocol as part of the quotation, and write the end-of-shelf-life CFU commitment into the contract instead of accepting a verbal assurance. Unusually low prices tend to show the same signals: no stated overage, no viable count testing, potency derived from weighed input rather than measured material, and a later path to revenue through expedite fees, artwork changes and re-testing. Reading the quote as five modules rather than one number is what makes those signals visible before the first purchase order.
